Arix Bioscience plc
(the "Company")
PDMR notification & Director Shareholding
The Company today announces it has granted an executive award of nil cost options (the "Award") under the Arix Bioscience plc Executive Incentive Plan (the "Plan") to CEO Robert Lyne, which are subject to performance conditions over a three-year period from 1 January 2023 to 31 December 2025 (the "Performance Period"). The Award takes the form of an option to acquire up to 671,800 ordinary shares of £0.00001 each in the Company. Vested Shares are subject to a further two-year holding period, as set out in the Plan. The performance conditions attached to the Award are set out in the Director's Remuneration Report on page 55 of Company's Annual Report & Accounts 2022.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Robert Lyne | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Chief Executive Officer | |||
| b)
| Initial notification /Amendment
| Initial Notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a)
| Name
| Arix Bioscience plc | |||
| b)
| LEI
| 213800OVT3AHQCXNIX43
| |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a)
| Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | |||
| Identification code | GB00BD045071 | ||||
| b)
| Nature of the transaction
| Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP") | |||
| c) | Price(s) and volume(s) | | Price(s) | Volume(s) | |
| | | Nil
| 671,800 | | |
| d)
| Aggregated information | | |||
| - Aggregated volume | N/A (Single Transaction) | ||||
| - Price | N/A (Single Transaction) | ||||
| e)
| Date of the transaction
| 30 May 2023 | |||
| f)
| Place of the transaction
| Outside a trading venue | |||
For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.